Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dr. Aziza Shad, Medical Director, The Aslan Project

Similar presentations


Presentation on theme: "Dr. Aziza Shad, Medical Director, The Aslan Project"— Presentation transcript:

1 Dr. Aziza Shad, Medical Director, The Aslan Project
The Building of a Sustainable Pediatric Cancer Health System in Ethiopia Dr. Aziza Shad, Medical Director, The Aslan Project September 23, 2017 9th Annual Ethio-American Health Care & Medical Education Conference

2 Why Invest in Pediatric Cancer? MOST CHILDHOOD CANCERS IN LICs
ARE CURABLE… Survival rates > 80% for children with cancer in high-resource countries Why Invest in Pediatric Cancer? …AT LOW COST TO THE SYSTEM… Using simple protocols and generic drugs <$1,000 …AND SAVE SIGNIFICANT PRODUCTIVE YEARS. An average of 71 productive years, benefiting families, communities, nations and the world

3 Building Blocks of A Pediatric Cancer Infrastructure:
The Aslan Project Approach

4 Building Blocks of Pediatric Cancer Infrastructure
Early and Accurate Diagnoses Effective Service Delivery Access to Essential Medicines, Resources & Health Information Systems Pediatric Oncology Units (Centers of Excellence) Stewardship Philanthropy & Advocacy

5 Early & Accurate Diagnoses
Community Awareness Timely Referral Accurate Diagnoses Pathologists trained in oncology-related testing/diagnoses Availability of necessary technologies and equipment Reagents Microscopes/IPath Flow cytometry Early & Accurate Diagnoses

6 Effective Service Delivery
Human Resource Development Palliative Care Parent and Family Support

7 Human Resource Development
Sufficient capacity in all specialty areas that support pediatric cancer care Pediatric hematology/oncologists Pathologists Pediatric surgeons Radiation oncologists Transfusion medicine specialists Pediatric oncology nurses Oncology pharmacies Psychologists and social workers Data managers Training programs pursuant to internationally-accredited curricula

8 Palliative Care From date of diagnosis to end of treatment
Access to adequate pain medication Compassionate communications

9 Parent & Family Support
Access to housing and transportation (free if needed) Nutritional supplementation Psychosocial supports – e.g., coffee ceremonies, counseling, art therapy Education/skill building

10 Access to and Affordability of Essential Infrastructures
Resources Medicines Supplies, Equipment & Medical Devices Health Information Systems, Research & Reporting

11 Essential Resources Blood products/Blood bank
Stable power source (incl. solar) Water IT bandwidth to ensure electronic function and communication

12 Essential Medicines Placement of all essential chemotherapy drugs, antibiotics, morphine, and other medications on National Essential Medicine List (NEML) National government supply chain management Stable and reliable pharmacy inventories Provision of drugs/treatment regardless of ability to pay

13 Supplies, Equipment & Devices
Government supply of: Personal protective equipment to ensure safety of nurses and pharmacists Biologic safety cabinets (hoods) for safe mixing of chemotherapy Prosthetics and other devices

14 Health Information Systems, Research & Reporting
Hospital-based data collection and management system Link to national cancer registry Monitoring & evaluation processes Research & reporting

15 Stewardship, Philanthropy & Advocacy
Financial support must come from international, national, and local sources – both public and private Local leader (pref. trained pediatric oncologist) needed to direct medical care and interact with institutional and national stakeholders Need for grassroots organization – e.g., private foundation – dedicated to raising awareness and funds and advocating on behalf of childhood cancer Stewardship, Philanthropy & Advocacy

16 Aslan video

17 Early Outcomes and Impact
Through ongoing advocacy with FMOH, most essential drugs now available More than 100 children treated Highly favorable early outcomes for LMIC Pioneered treatment for AML & use of ATRA Fellowship training program has offered exposure to world-class faculty from the United States, Canada, India, and Pakistan with intensive trainings abroad in US & India Ongoing training/mentorship in pathology – pathology residency training program to commence in 2018 Elevated standards of care in nursing, pharmacy Donation of biological safety cabinet Early Outcomes and Impact

18 Lessons Learned from Aslan’s Six Years in Ethiopia
To build a Comprehensive Pediatric Cancer Program, many partners are needed Partnership at the National, Local and Civil Society Level National: Federal Government Ethiopian Pediatric Society Local: Jimma University Tikur Ambessa Hospital Civil Society: TAPCCO Mathiwos Wondu-Ye Ethiopian Cancer Society Advocacy Lessons Learned from Aslan’s Six Years in Ethiopia

19 Lessons Learned from Aslan’s Six Years in Ethiopia
Partnership with the Ethiopian community in the USA Aslan is a US based non-profit organization Funding comes from private donations and some grants Not being Ethiopian, we are at a disadvantage Have some great Ethiopian ‘Friends of Aslan’ We would love to engage with others here to see how we can work together to ensure that every child with cancer in Ethiopia has access to care in the years to come. Advocacy Lessons Learned from Aslan’s Six Years in Ethiopia

20 Thank you for including The Aslan Project in this important conference
Join us on Oct. 14th in Washington, DC for our annual gala! For more information, contact


Download ppt "Dr. Aziza Shad, Medical Director, The Aslan Project"

Similar presentations


Ads by Google